Letters by company
Modine Manufacturing CO
9 letters discussing MOD. Everything written about it on this site is on its ticker page.
- Artisan Partners Artisan Global Discovery Fund Quarterly Commentary Artisan Global Discovery Fund reduced AI-infrastructure exposure by exiting Modine Manufacturing and Monolithic Power Systems, while concentrating capital in Lattice Semiconductor, Entegris and SiTime. The portfolio initiated Manhattan Associates, Okta and Clean Harbors, added to Twilio, West Pharmaceutical and RBC Bearings, and favored company-specific profit cycles amid higher rates, commodity costs and AI spending uncertainty. Q3 2026 CGNX $9.6BCLH $17BCOMP $7B
- Artisan Partners Artisan Small Cap Fund Quarterly Commentary Artisan Small Cap Fund trimmed Twist Bioscience, MACOM Technology Solutions and Modine after appreciation, while reducing Installed Building Products and Ascendis Pharma as their profit cycles faced setbacks. The team initiated Virtu Financial, Murphy USA and USA Rare Earth, and shifted software underweight as AI alters competitive dynamics and monetization prospects. Q2 2026 ASND $15BCIGI $4.4BFLEX $34B
- Artisan Partners Artisan Mid Cap Fund Quarterly Commentary Artisan Mid Cap Fund added to Lattice Semiconductor, Comfort Systems, Guardant Health, Teledyne and Tradeweb while initiating Entegris, Modine Manufacturing and C.H. Robinson Worldwide. The fund exited ROBLOX, Insulet and Cencora, arguing that AI infrastructure, health care innovation and selected profit-cycle recoveries offer better opportunities than maturing or competitively challenged franchises. Q2 2026 0HQW COR $65BENTG $21B
- Baird Equity Asset Management Q2 2026 Commentary and Market Outlook Baird Small/Mid Cap Growth added software, AI-infrastructure industrials and commercial-stage therapeutics while exiting holdings where conviction or the original thesis had weakened. The strategy argues that data-center spending supports demand for cooling, power and infrastructure, but maintains discipline as AI-led market leadership becomes increasingly concentrated. Q2 2026 AAON $6.4BAGYS $3.1BALKS $6.7B
- Artisan Partners Artisan Small Cap Fund Quarterly Commentary Artisan Small Cap Fund added to Modine Manufacturing and Twist Bioscience as data-center cooling, synthetic-biology demand and company execution strengthened conviction. The portfolio initiated Onto Innovation, Baldwin Group and Freshpet, while exiting Penumbra, JBT Marel and Parsons and reducing several positions on valuation, mandate size or weakening profit-cycle visibility. Q1 2026 BWIN $4.5BCOMP $7BFLEX $34B
- Artisan Partners Artisan Global Discovery Fund Quarterly Commentary The Global Discovery Fund added to Twist Bioscience, Sea, Compass, Medline, Spotify and Insmed, initiated Roblox, H World Group and ASM International, and exited JFrog, JBT Marel and Sartorius as conviction, valuation and profit-cycle prospects changed. It favors health care, AI infrastructure and aerospace and defense while treating software disruption and macro volatility as selective entry opportunities. Q1 2026 ASMXF $41BCOHR $52BCOMP $7B
- Choice Equities 2025 Q2 Investor Letter Choice Equities Fund added opportunistically to Magnite amid volatility and argues that streaming advertising, customer wins and potential ad-tech remedies can support its outlook. It also backs Genius Sports on renewed sports-data rights and Modine on data-center cooling demand, portfolio reshaping and operational improvements. second quarter 2025 GENI $1.8BMGNI $3.4BMOD $9.2B
- PenderFund Capital Management Ltd. Pender US Small/Mid Cap Equity Fund Manager’s Commentary, July 2026 Amazon’s accelerating AWS demand and long-lived data-centre infrastructure underpin the fund’s view that AI capital spending can earn attractive returns despite near-term volatility. The portfolio emphasizes smaller companies benefiting from power, cooling, compute and grid-investment demand, including Generac, Fluor, Modine and Microchip. JULY 2026 AMZN $2.7T
- Artisan Partners Quarterly Commentary: Artisan Small Cap Fund Artisan Small Cap Fund added to MACOM after temporary profit-cycle pressure, then trimmed it as valuation rose, while exiting Insmed, Integer Holdings and SharkNinja. The fund initiated nLIGHT, Guardant Health and Cellebrite, and increased Bruker, Hexcel and Penumbra on product-cycle, aerospace and medical-device adoption catalysts. Q4 2025 BRKR $8.6BCLBT $2.8BCOCO $3.4B
